Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
253280 ETF · RISE Healthcare ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -10.12%  | -11.38% | +4.35% | +24.34% | -7.20% | -3.62% | -16.90% | -14.07% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -11.38% | +4.35%  | +24.34% | -7.20% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 253280 ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
253280’s has a Final Sustainability Grade of either B+, B, or B-.
Replication
Issuer
| AuM | ||
|---|---|---|
148020 | RISE 200 ETF | €2.81B |
455890 | RISE Money Market Active ETF | €1.45B |
477080 | RISE CD RateActive(SYNTH) ETF | €828M |
475720 | RISE 200 Weekly Covered Call ETF | €569M |
479520 | RISE KOFR Active(SYNTH) ETF | €562M |
Frequently asked questions about 253280
What does RISE Healthcare ETF, 253280, invest in?
253280 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.
Which benchmark or index does 253280 replicate?
253280 tracks the FnGuide Inc Healthcare Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 253280?
253280 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
When was 253280 launched?
253280 was introduced to the market on September 23, 2016. It trades on Macedonia, The Former Yugoslav Republic of, among other exchanges
Who is the ETF issuer of 253280?
RISE Healthcare ETF, 253280, is provided by RISE ETF. Learn more about RISE ETF here.
What is the current assets under management (AUM) of 253280?
253280 oversees €5.3M in assets as of June 4, 2026.
How has 253280 performed lately?
Based on data from June 4, 2026, 253280 returned -10.12% over the past month, -11.38% over the last three months and -14.07% year-to-date.
What are the latest inflows or outflows for 253280?
As of June 4, 2026, 253280 recorded net flows of +€644K year-to-date.
Does 253280 distribute dividends?
253280 follows a distributing dividend policy, meaning it pays out income to investors. As of June 4, 2026, its 12-month trailing yield was 0.17%.
What are the main country or region exposures of 253280?
As of April 30, 2026, 253280 has significant geographic allocations in Republic of Korea.
In which sector or theme does 253280 invest in?
As of April 30, 2026, 253280 focuses largely on Health Care and Consumer Discretionary.
How many securities does 253280 hold and how diversified is it?
As of April 30, 2026, 253280 holds 37 positions in its portfolio, with 78.18% of assets concentrated in its top 15 holdings.
What are the main positions in 253280?
As of April 30, 2026, 253280 top three holdings include CELLTRION, SAMSUNG BIOLOGICS CO LTD and HLB.
What is the base currency of 253280?
The base currency of 253280 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
